May 20
LAVAL, QC, May 20 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced that it has completed the previously announced transaction to establish a joint venture with Gruppo Angelini. The joint venture, Angelini Labopharm, will launch OLEPTRO(TM), Labopharm's novel once-daily formulation of trazodone indicated for the treatment of major depressive disorder in adults, in ...
May 12
NEW YORK , May 12 /PRNewswire-FirstCall/ -- Aoxing Pharmaceutical Company (NYSE Amex��AXN) ("Aoxing Pharma") today announced that Chinese government successfully hosted a joint venture signing ceremony on the behalf of Aoxing Pharma and Johnson Matthey Plc earlier today on May 12, 2010 . � Tomorrow, Aoxing Pharma will host a conference call to discuss the joint venture ("Joint Venture ...
Apr 29
HSINCHU, Taiwan, April 29 /PRNewswire-Asia-FirstCall/ -- AU Optronics Corp. ("AUO" or the "Company") (TAIEX: 2409; NYSE: AUO) held a meeting of the Board of Directors on April 29, 2010, at which the Board approved a resolution establishing a joint venture of TFT-LCD TV panel module production with TCL Multimedia Technology Holdings Limited's subsidiary, TCL King Electrical Appliances (Hui Zhou ...
Apr 29
HSINCHU, Taiwan, April 29 /PRNewswire-Asia-FirstCall/ -- AU Optronics Corp. ("AUO" or the "Company") (TAIEX: 2409; NYSE: AUO) held a meeting of the Board of Directors on April 29, 2010, at which the Board approved a proposition establishing a joint venture of TFT-LCD TV panel module production with Haier Group (Haier) in Haier Industrial Park, Qingdao, Shandong.
Oct 26
Ballard Reports Third Quarter 2009 Results VANCOUVER, Oct. 26 /PRNewswire-FirstCall/ — Ballard Power Systems (TSX: BLD; NASDAQ: BLDP) announced revenue of $9.0 million, a decrease of $3.3 million from the same period last year, and net loss of $12.0 million, an improvement of $3.5 million, for the third quarter ended September 30, 2009. Normalized net loss(1) of $7.2 million reflects an improvement of $6.1 million relative to the third quarter of 2008. All amounts are in U.S. dollars, unless o
